Tivity Health Inc Forecasted to Post Q2 2019 Earnings of $0.74 Per Share (TVTY)

Tivity Health Inc (NASDAQ:TVTY) – Equities research analysts at Piper Jaffray Companies issued their Q2 2019 earnings per share (EPS) estimates for Tivity Health in a research report issued to clients and investors on Thursday, May 9th. Piper Jaffray Companies analyst S. Wieland forecasts that the company will earn $0.74 per share for the quarter. Piper Jaffray Companies currently has a “Overweight” rating and a $33.00 target price on the stock. Piper Jaffray Companies also issued estimates for Tivity Health’s Q3 2019 earnings at $0.63 EPS, Q4 2019 earnings at $0.51 EPS, FY2019 earnings at $2.39 EPS, Q1 2020 earnings at $0.62 EPS, Q2 2020 earnings at $0.73 EPS, Q3 2020 earnings at $0.71 EPS, Q4 2020 earnings at $0.63 EPS and FY2020 earnings at $2.70 EPS.

TVTY has been the subject of several other research reports. BidaskClub upgraded shares of Tivity Health from a “strong sell” rating to a “sell” rating in a report on Monday, April 1st. Cantor Fitzgerald restated a “buy” rating on shares of Tivity Health in a report on Monday, April 22nd. Barrington Research restated an “outperform” rating and set a $40.00 target price on shares of Tivity Health in a report on Wednesday, February 20th. They noted that the move was a valuation call. Chardan Capital restated a “buy” rating and set a $31.00 target price (down previously from $41.00) on shares of Tivity Health in a report on Friday, February 1st. Finally, Jefferies Financial Group reduced their target price on shares of Tivity Health to $29.00 and set a “buy” rating for the company in a report on Wednesday, February 20th. One research analyst has rated the stock with a sell rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company. Tivity Health presently has a consensus rating of “Buy” and a consensus price target of $33.00.

Shares of TVTY opened at $19.01 on Monday. Tivity Health has a 12 month low of $16.25 and a 12 month high of $41.46. The firm has a market cap of $905.83 million, a P/E ratio of 8.12, a price-to-earnings-growth ratio of 0.82 and a beta of 1.10. The company has a quick ratio of 0.96, a current ratio of 0.86 and a debt-to-equity ratio of 2.13.

Tivity Health (NASDAQ:TVTY) last announced its earnings results on Wednesday, May 8th. The company reported $0.51 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.50 by $0.01. Tivity Health had a net margin of 12.18% and a return on equity of 26.02%. The business had revenue of $214.10 million during the quarter, compared to analysts’ expectations of $200.39 million. During the same quarter in the prior year, the company posted $0.49 earnings per share. The firm’s revenue was up 42.8% on a year-over-year basis.

Hedge funds and other institutional investors have recently bought and sold shares of the business. Piedmont Investment Advisors Inc. raised its position in shares of Tivity Health by 5.5% in the fourth quarter. Piedmont Investment Advisors Inc. now owns 9,729 shares of the company’s stock valued at $241,000 after purchasing an additional 511 shares during the period. Victory Capital Management Inc. raised its position in shares of Tivity Health by 4.1% in the fourth quarter. Victory Capital Management Inc. now owns 17,112 shares of the company’s stock valued at $425,000 after purchasing an additional 667 shares during the period. State of Alaska Department of Revenue raised its position in shares of Tivity Health by 5.7% in the fourth quarter. State of Alaska Department of Revenue now owns 13,691 shares of the company’s stock valued at $339,000 after purchasing an additional 737 shares during the period. Advisor Group Inc. raised its position in shares of Tivity Health by 364.2% in the fourth quarter. Advisor Group Inc. now owns 1,142 shares of the company’s stock valued at $29,000 after purchasing an additional 896 shares during the period. Finally, Enlightenment Research LLC bought a new position in shares of Tivity Health in the fourth quarter valued at about $37,000. 94.73% of the stock is currently owned by hedge funds and other institutional investors.

In other news, Director Bradley S. Karro purchased 2,900 shares of the company’s stock in a transaction on Friday, March 22nd. The shares were purchased at an average cost of $16.54 per share, with a total value of $47,966.00. Following the completion of the transaction, the director now owns 24,696 shares of the company’s stock, valued at approximately $408,471.84. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Sara Finley purchased 2,000 shares of the company’s stock in a transaction on Wednesday, March 20th. The shares were purchased at an average cost of $17.25 per share, for a total transaction of $34,500.00. The disclosure for this purchase can be found here. Corporate insiders own 1.64% of the company’s stock.

About Tivity Health

Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers.

Featured Story: What Factors Can Affect Return on Equity?

Earnings History and Estimates for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.